Neuroguard IEP System
Commercial- Indications
- Carotid artery disease
Company intelligence / Profile preview
Contego Medical
Raleigh, North Carolina, United Statescontegomedical.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Contego Medical’s integrated embolic protection systems have demonstrated strong clinical outcomes. The PERFORMANCE II study showed best reported outcomes among carotid artery stenting systems. Over 3,000 patients have been treated with their devices to date.
- Therapeutic areas
- Cardiovascular
- Modalities
- DeviceIntegrated embolic protection systemStent systemBalloon angioplasty system
- Industry
- Surgical Medical Devices
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Medtronic (sole distributor of Neuroguard product line in United States as of June 2024)
Beyond the preview
Go deeper on Contego Medical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Contego Medical.